Target intelligence / Profile preview

Extracellular environment (ECS)

Target
ECS
Molecular classification
Other
01

Overview

The extracellular environment encompasses the entire region outside of the cell membrane, primarily consisting of the interstitial fluid and the extracellular matrix (ECM) (Wikipedia, 2024). It serves as a critical scaffold for tissue architecture and a reservoir for signaling molecules such as growth factors and cytokines (StatPearls, 2023). Although the extracellular environment as a whole is not considered a discrete therapeutic target, many of its individual components, including enzymes like matrix metalloproteinases and structural proteins like collagen, are significant focal points for drug development (Nature Reviews Drug Discovery, 2020). Dysregulation of this environment is central to the pathogenesis of diseases such as cancer, where the ECM is remodeled to promote tumor invasion, and fibrosis, characterized by excessive protein accumulation (Journal of Cell Science, 2021). Drugs often operate within this space or target specific extracellular proteins to modulate cell signaling and tissue integrity (Pharmacological Reviews, 2019). Because it is a biological compartment rather than a single molecule, it lacks a specific mechanism of action or direct drug interactions in the traditional pharmacological sense. Understanding the physical and chemical properties of this environment, such as pH and oxygen tension, is vital for optimizing drug delivery and efficacy (Advanced Drug Delivery Reviews, 2022).

Other names
Extracellular spaceInterstitial spaceExtracellular matrix (ECM)Interstitial fluid
02

Mechanism of action

Not applicable as this is a biological compartment rather than a specific molecular target.

03

Biological functions

Signal transductionStructural supportHomeostasisNutrient transportCell migrationOther
04

Disease associations

CancerInflammationNeurodegenerative diseaseCardiovascular diseaseOther
05

Safety considerations

Lack of molecular specificityPotential for systemic off-target effectsChallenges in drug penetration and distributionToxicity related to altering tissue architecture
06

Biomarkers

Matrix metalloproteinases (MMPs)Collagen fragments (e.g., C-terminal telopeptide)Lactate levelsExtracellular pHFibronectin levels

Beyond the preview

Go deeper on Extracellular environment (ECS).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Extracellular environment (ECS).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call